Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

October 21, 2013

The Clinical Research Landscape in Latin America

Speakers for this Event:
  • Mauro Martinelli, Emerging Markets Specialist, Quintiles
  • Jose Emilio, Associate Director, Clinical Operations, Quintiles
  • Emerging Markets are becoming increasingly relevant as part of global clinical trials. Growth of the middle class and a change in lifestyle leads to in an increased prevalence of typically Western World diseases. Attractive growth rates of individual markets. Result: increased demand for tailored treatments for the local population. Despite the attractiveness of the region, there are some local specifics to be considered before including Latin America in your study.

    Join us for this complimentary webinar and learn about:

    • Top level regional demographic characteristics
    • Current regional pharmaceutical market and healthcare expenditure 
    • Prevalence of main Indications in the region
    • Overview of Regulatory environment

    The need for leaner, faster and cost effective clinical trials demands more attention on where to target enrollment. Pharmaceutical companies that have seldom worked outside the US and EU in the past will need to assess going to other markets. Latin America has a key role to play in this regard. These companies will expect more from their providers in terms of advice and accountability. This webinar will explore those key strengths that customers are seeking in order to move towards Emerging Markets.


    Senior level executives from pharma/biotech companies involved in:

    • Clinical Research
    • Outsourcing / Procurement
    • Clinical Operations
    • Regulatory Affairs
    • Project Management

    Mauro Martinelli, Emerging Markets Specialist, Quintiles

    Mauro Martinelli has a biochemist degree from the “Universdidad de Buenos Aires and has more than 14 years of experience in Clinical Research. Since 2006, Mauro has been working with global and local customers to include Latin America as part of global studies.

    Based in Washington DC since 2009, his main focus has been detailed information on Latin America in relation to therapeutic focus, regulatory environment and resulting requirements, local policies, available patient profiles, as well as providing recommendations on country selection for specific clinical trials. Depending on the study objective, Mauro could successfully assist companies based in US or EU to include Latin America in their global studies, or work directly with Latin America based companies to set-up their local study in the most efficient way.

    Previous to his current position, Mauro worked over six years in Clinical Operations for Quintiles, based in Buenos Aires, Argentina. During this time, he covered activities from monitoring to study management (Phase IIb, III and IIIb) across US, Latin America and Europe.

    Jose Emilio, Associate Director, Clinical Operations, Quintiles

    With 13 years of experience in Academic and Clinical Research in Pharmaceutical companies and CRO across the Latin America region, Jose Emilio, Associate Director, Clinical Operations, is responsible for:

    • Clinical Operations Management - Direct clinical monitoring group management to ensure projects are appropriately resourced and employees are trained and developed to meet project needs within high quality standards.
    • Customer and Project Management - Analysis of company and clients strategy including pipeline, programs review, direct control of the delivery against key metrics, scope of work, budget, quality of deliverables following Good Clinical Practices, ICH Guidelines and all applicable local regulations
    • Wide experience in various functions such as CRA, Clinical Team Lead, Clinical Operations Manager, Project Manager and Site Identification group Manager across the Latin America region.
    • People management - performance, coaching, actions plan and general support for staff development.

    Quintiles is the only fully integrated biopharmaceutical services company offering comprehensive solutions worldwide across the product lifecycle. Our network of more than 27,000 professionals in 100 countries has an eye on the future while delivering results today with an unwavering commitment to patients, safety and ethics. Quintiles helps biopharmaceutical companies develop and commercialize products to improve and lengthen patients’ lives while demonstrating value to stakeholders.

    As a pioneer in biopharmaceutical services, Quintiles has helped develop or commercialize all of the top 50 best-selling drugs during our 30 years of experience. We have supported over 80 product launches in the US, including 25 companies who were launching a product for the first time. The benefits of our partnership model include retention of strategic control, long term value maximization, operational risk management, and corporate and operational flexibility, and hence offers an attractive alternative to traditional co-promotion and out-licensing approaches.

    Please visit our website for more information.

    For information about the recorded archive for this event contact Xtalks at (416) 977-6555 ext 371, or email register@xtalks.com

    Share this:
    Copyright © 2016-2017 Honeycomb Worldwide Inc.